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Abstract Approximately 30 cases of LCHAD defi-
Background—Long chain 3-hydroxy- ciency have been reported in the literature. ' H 17
acyl-CoA“ dehydrogenase (LCHAD) is one Symptoms are provoked by an insufficient pro
of the enzymes involved in the breakdown duction of ketone bodies during starvation,
of fatty acids. A deficiency of this enzyme leading to a severe, life threatening hypoketotic
is associated with life threatening episodes hypoglycaemia. The pattern of organic acids in
of hypoketotic hypoglycaemia during pro- body fluids at times of stress or during
longed fasting. Neuropathy and retinopig- provocative tests, such as prolonged carefully
m entary changes were mentioned in only controlled fasting and/or long chain triglycer-
a few cases. ide loading is indicative of the different enzyme
M ethods—The case histories of two girls, defects involved in fatty acid oxidation. Defini­
tive proof can be obtained by enzyme assays inaged 8 and 15 years, with LCHAD defi­
ciency are reported.
Results—Both children with LCHAD de- lymphocytes.12 Most patients with LCHAD
cultured skin fibroblasts or isolated
ficiency exhibited extensive macular pig­
m entary depositions and a ‘salt and 
pepper’ scattering of pigment in
deficiency have a G —> C mutation at position 
1528 of the cDNA encoding the a subunit, 
their resulting in a glutamate to glutamine transi-
retinas. The patients have decreasing 
visual acuity.
Conclusion—The early recognition of
tion. This base substitution creates a Pst I 
restriction site making mutation analysis by 
PCR-RFLP possible.18 LCHAD deficiency has
LCHAD deficiency can increase the life b ,_ e e n  “ sedated with myopathy, cardiomyopa- 
expectancy in these patients through th-v’ “ «m utent rhabdomyolys.s, polyneu-
avoiding catabolism and through appro­
priate diets. Patients tend to be free of 
symptoms between attacks, however. Test­
ing for the disorder, therefore, should be 
included in the diagnostic process for 
children with retinal dystrophy, in par­
ticular when other clinical symptoms are 
known to have occurred.
(.B r J  Ophthalmol 1997 ;81 :291-294)
ropathy, Reye-like syndrome, and sudden 
unexpected death syndrome.1110There can 
be a sudden onset of symptoms during the first 
year of life without previous signs of illness. 
This disease has a high rate of morbidity and 
mortality.
Very recently retinal dystrophy was shown to 
be associated with LCHAD deficiency.1' 1(’20 In 
these reports, the retinal findings were de­
scribed as retinitis pigmentosa1" and pigmen­
tary retinal degeneration.'1 Until now, detailed 
ocular findings and the results of electroretino-Fatty acids are a major source of metabolic fuel
in humans. The oxidation of long chain fatty f  have not been reported in cases oi
acids, the most abundant in our daily diets, ^CHAD deficiency, 
predominantly occurs in mitochondria. In
recent years an increasing number of inherited p atientS5 methods, and results
enzyme defects of fatty acid oxidation such as This paper describes the case histories of two
LCHAD deficient girls and focuses on their 
retinal dystrophy.
The first patient, a girl, was born at term fol
long chain 3-hydroxy-acyl-CoA dehydrogenase 
(LCHAD) deficiency have been recognised.1 
LCHAD is a mitochondrial, membrane bound
enzyme that is specific for the long chain lowing an uncomplicated pregnancy and deliv-
substrates.2 It dehydrogenates 3-hydroxy-acyl- ery in March 1988 as the third child of appar-
CoA compounds of 12 to 18 carbon length, ently healthy, non-consanguineous white
and is multifunctional, also exhibiting 2-enoyl- parents. Her medical history and the biochemi-
CoA hydratase and 3-ketoacyl-CoA thiolase Cal investigations were reported earlier." 14 She
activities.14 LCHAD is part of the so called was examined thoroughly and monitored,
mitochondrial trifunctional protein (MTP), an because the first child in this family unexpect-
enzyme complex consisting of four a and four edly died on the third day after birth. At the age
(3 subunits. The a subunit harbours LCHAD of 5 months she was hospitalised after having
activity.5 Using fluorescence in situ hybridisa- suffered from gastrointestinal problems for a
tion (FISH) the gene for the a subunit was 
localised to chromosome 2.6
few days. Physical examination showed a hypo­
tonic, lethargic, unresponsive, and pale infant
Autosomal recessive inheritance is suggested with staring eyes. Most probably, these symp-
by the intermediate levels of LCHAD activity 
in the parents of two patients.7 8
toms were caused by the observed hypoketotic 
hypoglycaemia. During this period of hospitali-
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Figure 1 First patient> right eye. Macula with strong 
hyperpigmentation and some clustering of pigment.
Figure 2 First patienty right eye. Salt and pepper 
pigmentation, changing into a ring of clumped pigment in 
the m id periphery.
sation, she had two similar episodes and selec- oped normally until the age of 6 months, when
tive screening of body fluids was indicative of a feeding problems and vomiting began. Subse-
deficiency in fatty acid (3 oxidation, most prob- quently, failure to thrive and motor develop
ably LCHAD. This was confirmed by subse- ment stagnation caused her to be hospitalised,
quent enzyme activity measurements. RFLP Physical examination revealed severe muscle
analysis in this patient revealed the common weakness and hypotonia. She cried weakly and
G —> C 1528 mutation in the LCHAD DNA. was pale and lethargic. At that time her weight
Treatment was started with a high carbohy- was 1 kg below the third percentile expected
drate, medium chain fatty acid enriched diet. 
On ophthalmic examination during her first
for her age.
The clinical and chemical findings in con- 
year of life, the girl had a ‘salt and pepper5 pig- nection with the urinary organic acid profile 
mentation in the fundi of both eyes. The elec- indicated that she was suffering from a 
troretinogram was within the normal range, deficiency in fatty acid (3 oxidation, and
there were no signs of visual impairment, and 
no strabismus. The next electroretinogram was
eventually she was diagnosed as having 
LCHAD deficiency.12 RFLP analysis revealed 
made in 1993, when she was 5 years old. It the common G —> C 1528 mutation in the 
shows normal latency time and normal ampli- LCHAD DNA.
She was examined ophthalmically in 1986. 
Visual acuity of die right eye was 20/20 with S
tude of the b-wave during both scotopic and 
photopic conditions.
In October 1994, the child spontaneously 1.0 C —1.0 180° and that of the left eye
complained about decreased vision in the dark. 20/25 with S -1 .5  = C -1 .5  180°. Her myopia
Additional examination of the visual system is most probably because of a familial myopia;
revealed that visual acuity, with sphere (S) her father, for example, is myopic S -7 . The
cylinder (C) -1.25 90°, was 20/25 in orthoptic tests and biomicroscopy showed no
, abnormalities. During ophthalmoscopy, how-
-0.25 =
the right eye and, with S -0 .50 = C -1 .25  95
was 20/25 in the left eye. Visual field ever, hyperpigmentation was found in the 
examination had not yet been performed, in periphery as well as in the centre of the retina.
view of the young age of the patient. The diag At the age of 10 the patient complained
nosed ocular abnormalities were limited to the about visual deterioration. She had a reduction 
fundus. Ophthalmoscopy showed a blond fun- in her field of view, decreased vision at dusk 
dus, which is most probably associated with the and night, as well as photophobia in bright 
blond hair and blue eyes of the patient. The light. With optimal correction, visual acuity of 
papillae were normal and so were the retinal the right eye was still 20/20, but that of the left 
vessels. The appearance of the macula, how- eye had decreased to 20/40. Ophthalmoscopy 
ever, was abnormal in both eyes: it showed revealed pale discs, somewhat narrowed ves- 
strong hyperpigmentation with some cluster- sels, hyperpigmentation, and pigment clusters 
ing of the pigment (Fig 1). In the mid periph- in the posterior pole with some sickle-shaped 
ery there was an area with atrophy and next to hyperpigmentation in the periphery. Addi- 
it an arch of salt and pepper pigmentation, tional examination of the visual system re­
changing into a ring of clumped pigment (Fig vealed that contrast vision was reduced for the 
2). Salt and pepper pigmentation was visible left eye in the middle and high frequencies, 
further into the periphery, while the retina had Colour vision (Panel tests) was almost normal 
a virtually normal appearance in the extreme for the saturated test and highly abnormal in all 
periphery. In addition, there were focal depig- directions for the unsaturated test version type, 
mented spots scattered across the entire retina, especially for the left eye.
The left eye showed hyperpigmentation along The basic value of the electro-oculogram in
the edge of the papilla. The vitreous gel was the dark was normal with a decreased light rise,
clear. The EOG Arden ratio was approximately 1.3
The second patient, also a girl, was the and 1.4. In the electroretinogram, amplitudes
second child of apparently healthy non- somewhat less than 50% of the lower limit of
consanguineous white parents. She was born at the normal value both for the rod and cone
term in September 1980 after an uneventful system were found. The pattern evoked occipi-
pregnancy and a normal delivery. She devel- tal potentials were delayed and decreased for
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cause and the fundamental pathophysiology of 
retinal dystrophy are as yet unknown but since 
they are frequently observed in inherited errors 
of metabolism it is suspected that they might 
be induced by toxic effects of certain metabo­
lites, errors of synthetic pathways, or deficient 
energy metabolism.1'1
One of the inherited disorders of metabolism 
associated with retinal dystrophy can be caused 
by deficient LCHAD activity.1“21 Only recently 
retinal dystrophy was mentioned in LCHAD 
deficiency but detailed information about the 
retinal changes was not given. Electrophysiol­
ogy was not performed in 4-1---- — j : " 1,1 2,1
Figure 3 Second patient, right eye. Global viczo of 
posterior pole and mid periphery.
We describe striking retinal dystrophy in two 
young patients. In our first case, the central 
part of the retina was affected in the early 
stages of this metabolic disorder. However, the 
normal electroretinographic results in both 
scotopic and photopic conditions did not sup­
port a cone-rod degeneration. As yet, the 
patient has subnormal vision.
If there is destruction of the retinal recep­
tors, the electroretinogram will decrease and 
eventually become completely extinguished. 
The implicit time of the b-wave is usually 
delayed, reflecting dysfunction of the retinal 
neurons before destruction so that it can be 
used as an early sign of a progressive disease. A 
decrease in amplitude reflects the degree of 
neuronal destruction that may occur somewhat 
independently of implicit time changes that 
tend to reflect more diffuse retinal pathology.22 
In our experience, a rather good electroretino­
gram compared with fundus changes and 
the left eye, whereas those of the right eye were visual field abnormalities can sometimes occur
Figure 4 Second patient, right eye. Clumped 
hyperpigmentation in the periphery.
within the normal range.
At the age of 13 years, visual acuity had fur­
ther deteriorated—for the right eye it was
20/30 with S -7  = 
eye 3/60 with S —8.0. The patient had a central 
scotoma in the visual field. The ability to see 
contrast decreased after the test in 1991, while 
the results of the saturated and unsaturated 
Panel test of colour vision have not changed 
significantly. The electroretinograms of the rod
in secondary retinal degenerations, as well as in 
dominantly inherited retinal dystrophies.
A deterioration of the electroretinogram
C —1.0 180° and for the left witii time appears not to have occurred in the
case of the second patient either: her second 
electroretinogram shows an improvement from 
50% to approximately 75%. We believe, 
however, that this was not an actual improve­
ment, but rather was caused by the problems 
experienced while examining the patient dur-
and cone system were approximately 75%. The ing the first test. All other functional tests
girl was extremely difficult to examine the first showed a remarkable deterioration of vision in 
time and rather difficult the second time. This
probably is the reason for the apparent
improvement. A third electrodiagnostic
examination was refused by the parents.
At the age of 14, she was seen again. Accord­
ing to the mother, her vision deteriorated and
the left eye and a further deterioration was 
observed at the age of 14 years. Furthermore, 
there is a clear increase in retinal dystrophy in 
the macula and throughout the retina.
The actual cause of the observed retinal dys­
trophy in LCHAD deficiency is unknown. So
she had more problems at school. Visual acuity far it is not known if the LCHAD gene is
for the right and left eye was 20/30 and 2/60 
respectively. The vision of 20/30 was achieved 
with a small central rest in the visual field. The 
left eye had a deep central scotoma. Ophthal­
moscopy showed pale optic discs, hypopig­
mentation, and hyperpigmentation in the pos­
terior pole (Fig 3) and clumped pigment in the 
periphery of the retina (Fig 4).
expressed in the pigment epithelium. Whether 
or not the accumulation of long chain acyl car­
nitines, observed in LCHAD deficiency, are 
involved in the pathophysiology of the retinal 
dystrophy is subject to further investigation.
The treatment of LCHAD is
Discussion
based on the supplementation of medium 
chain triglycerides, which can be metabolised 
normally, as opposed to the long chain triglyc­
erides which cannot. The patients are develop-
Retinal dystrophy in children may be ing normally on this diet.
primary—that is, without other systemic mani- Although patients with LCHAD deficiency
festations or secondary and associated either usually develop symptoms within the first 6 
with non-metabolic genetic syndromes or with months, these symptoms vary greatly and can 
inherited metabolic disorders.19-21 The actual be highly non-specific. Early diagnosis, how-
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ever, is very important in view of the life 
expectancy for these children. In children, 
LCHAD deficiency and other inherited errors 
of metabolism should consequently be consid­
ered whenever retinal dystrophy is observed.
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